Our approach
Drawing on years of expertise, we’ve built a holistic and streamlined drug discovery engine that captures complex human disease biology in vitro, overcoming key technical barriers in phenotypic screening.
Our platform exploits outstanding expertise in complex human (and patient-based) cellular disease modeling, assay automation and validation, together with key assets in AI-powered phenotypic profiling and data integration to reveal novel therapeutic opportunities.
PREDICTIVE.
Complex patient-based models. AI allows us to tackle intrinsic batch-to batch variability and to establish authentic and predictive disease models.
SCALABLE.
“Scalability thinking” from the start. Our Image & Data mining team develops tailored algorithms to deal with large amounts of biological data generated in house from automated assays.
INTERPRETABLE.
Tailored algorithms. Our team develops tailored algorithms to extract information from large datasets generated in house and enrich / corroborate with external data.
Enabled by AI
The power of AI is key for our high content image data analysis. We use Profiling and Deep Learning methodologies to analyse thousands of subtle morphometric read-outs, allowing for the compensation of inherent variability of complex cellular and patient-based disease models. AI also enables fast interpretation of our generated imaging datasets, deciphering human disease biology.
Our strength in morphometric profiling of complex cellular and patient-based assays sets us apart in the field.
